Danbi Lee Selected Research

Danbi Lee Research Topics

Disease

37	Hepatocellular Carcinoma (Hepatoma) 11/2022 - 06/2007
17	Neoplasms (Cancer) 11/2022 - 05/2012
12	Chronic Hepatitis B 01/2022 - 06/2007
6	Fibrosis (Cirrhosis) 11/2018 - 08/2014
4	Liver Cirrhosis (Hepatic Cirrhosis) 01/2022 - 05/2015
3	Hemorrhage 01/2022 - 01/2015
3	Chronic Hepatitis C 01/2021 - 06/2014
3	Neoplasm Metastasis (Metastasis) 11/2016 - 09/2009
3	Liver Neoplasms (Liver Cancer) 12/2015 - 04/2013
2	Neuroinflammatory Diseases 12/2022 - 11/2020
2	Ascites 05/2022 - 01/2020
2	Stomach Neoplasms (Stomach Cancer) 05/2022 - 01/2019
2	Hepatitis 01/2022 - 06/2013
2	Disease Progression 04/2021 - 01/2019
2	Acute Liver Failure (Fulminant Hepatic Failure) 10/2019 - 01/2017
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2019 - 09/2006
2	Lymphoma (Lymphomas) 01/2019 - 01/2016
2	Autoimmune Hepatitis 01/2019 - 01/2016
2	Infections 01/2016 - 05/2012
2	Liver Diseases (Liver Disease) 01/2016 - 01/2015
2	Hepatitis B 01/2016 - 12/2014
2	Thrombosis (Thrombus) 03/2015 - 05/2012
1	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2022
1	Peritoneal Neoplasms 05/2022
1	Atrial Fibrillation 01/2022
1	Esophageal and Gastric Varices (Esophageal Varices) 01/2022
1	Varicose Veins (Varicose Vein) 01/2022
1	Ovarian Neoplasms (Ovarian Cancer) 11/2021
1	Inflammation (Inflammations) 03/2021
1	Cholangiocarcinoma 01/2021
1	Type 2 Diabetes Mellitus (MODY) 10/2020
1	Hepatic Encephalopathy 01/2020
1	Acute-On-Chronic Liver Failure 10/2019
1	Stroke (Strokes) 01/2018

Drug/Important Bio-Agent (IBA)

6	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2022 - 08/2014
6	Proteins (Proteins, Gene)FDA Link 11/2020 - 02/2011
5	Alanine Transaminase (SGPT)IBA 11/2022 - 04/2013
5	DNA (Deoxyribonucleic Acid)IBA 11/2021 - 05/2012
5	Sorafenib (BAY 43-9006)FDA Link 04/2021 - 01/2013
5	entecavir FDA Link 01/2017 - 06/2012
5	Lamivudine (Epivir)FDA Link 01/2016 - 01/2011
4	Antiviral Agents (Antivirals)IBA 01/2021 - 01/2011
3	Fetal Proteins (Fetoprotein)IBA 12/2015 - 04/2013
3	Neoplasm Antigens (Tumor Antigens)IBA 12/2014 - 11/2012
3	InterferonsIBA 06/2013 - 06/2007
2	RNA (Ribonucleic Acid)IBA 11/2022 - 01/2018
2	Phosphotransferases (Kinase)IBA 01/2022 - 03/2021
2	Serum AlbuminIBA 10/2021 - 12/2015
2	NivolumabIBA 07/2020 - 07/2020
2	Biomarkers (Surrogate Marker)IBA 01/2019 - 01/2016
2	Immunoglobulin G (IgG)IBA 01/2019 - 01/2016
2	A Kinase Anchor ProteinsIBA 11/2018 - 01/2018
2	Hepatitis B e AntigensIBA 01/2017 - 08/2014
2	adefovirIBA 07/2013 - 06/2012
2	HLA-DRB1 Chains (HLA DRB1)IBA 05/2012 - 01/2011
2	HLA Antigens (Human Leukocyte Antigens)IBA 05/2012 - 01/2011
2	lipoarabinomannan (LAM)IBA 02/2012 - 01/2011
1	hispidolIBA 12/2022
1	Biological ProductsIBA 12/2022
1	Monoamine Oxidase (MAO)IBA 12/2022
1	Iodized OilIBA 02/2022
1	AnticoagulantsIBA 01/2022
1	tenofovir alafenamideIBA 01/2022
1	cabozantinibIBA 01/2022
1	Tenofovir (Viread)FDA Link 01/2022
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2022
1	Warfarin (Coumadin)FDA LinkGeneric 01/2022
1	Carboplatin (JM8)FDA LinkGeneric 11/2021
1	Bevacizumab (Avastin)FDA Link 04/2021
1	lenvatinibIBA 04/2021
1	atezolizumabIBA 04/2021
1	LipopolysaccharidesIBA 03/2021
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 03/2021
1	Amyloid (Amyloid Fibrils)IBA 11/2020
1	Plant Growth Regulators (Plant Hormones)IBA 11/2020
1	Abscisic AcidIBA 11/2020
1	Glyburide (Glibenclamide)FDA LinkGeneric 10/2020
1	regorafenibIBA 07/2020
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 01/2020
1	asunaprevirIBA 10/2019
1	daclatasvirIBA 10/2019
1	Cell-Free Nucleic AcidsIBA 01/2019
1	Circulating Tumor DNAIBA 01/2019
1	Epithelial Cell Adhesion MoleculeIBA 11/2018
1	ElastinIBA 11/2018
1	Messenger RNA (mRNA)IBA 11/2018
1	Collagen Type I (Type I Collagen)IBA 11/2018
1	Thioacetamide (Thioacetamid)IBA 11/2018

Therapy/Procedure

20	Therapeutics 04/2021 - 06/2007
6	Drug Therapy (Chemotherapy) 05/2022 - 09/2006
6	Liver Transplantation 01/2020 - 05/2015
5	Radiotherapy 04/2022 - 03/2015
2	Salvage Therapy 02/2022 - 09/2006
2	Hepatectomy 01/2020 - 01/2012
2	Radiofrequency Ablation 12/2015 - 12/2013
1	Minimally Invasive Surgical Procedures 05/2022
1	Immunotherapy 01/2022
1	Ligation 03/2020
1	Gastrectomy 01/2019
1	Activities of Daily Living (ADL) 01/2018